Skip to main content
Clinical Trials/ITMCTR1900002339
ITMCTR1900002339
Not Yet Recruiting
Phase 1

A Randomized Controlled Trial for Knee Osteoarthritis Treated by Acupotomy under Ultrasound Location of Muscle and Bone

anjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
anjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
anjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) To meet the diagnostic criteria of knee osteoarthritis of American College of Rheumatology;
  • (2\) For most days in the past month, knee pain was at least moderate and below (VAS score 7\);
  • (3\) Aged 40 to 75 years;
  • (4\) Subjects stopped taking analgesics and took related drugs only when pain was intolerable, such as analgesics or non\-steroidal anti\-inflammatory drugs. Subjects were not allowed to take hormone drugs and agreed not to change drugs at will during the course of treatment;
  • (5\) Willing to sign informed consent.

Exclusion Criteria

  • (1\) those who received hormone therapy in the past three months;
  • (2\) Intra\-articular hyaluronidase injection in the past six months;
  • (3\) Joint irrigation or arthroscopy was performed in the past 1 year;
  • (4\) Diseases that hinder the safe participation of experimental design and affect the completion of research, such as severe systemic diseases such as myocardial infarction or stroke, congestive heart failure, severe chronic obstructive pulmonary disease, cancer, diabetes and severe mental illness in the past three months;
  • (5\) Physical history or clinical manifestations with bleeding tendency, including the current use of anticoagulants;
  • (6\) Inflammatory arthritis (such as rheumatoid arthritis or psoriasis type). Before inclusion, the subjects will be tested for rheumatoid factor, erythrocyte sedimentation rate and anti\-O, excluding the possibility of rheumatoid arthritis.

Outcomes

Primary Outcomes

Not specified

Similar Trials